Thomas Charles Rogers

2019

Ask Donna

Pull out the substance of this filing.

What was filed

  • 110

    investments

  • 0

    positions

  • 0

    gifts

  • 0

    agreements

  • 0

    debts

  • 0

    reimbursements

  • 0

    income

  • 0

    spouse income

As filed

1.25 a Florence C (1/2011, $10,000) — None

Brokerage account # 1 (Marked as # 1)

First Clearing, LLC - Cash balance — None

# 1 - AT&T Inc. — Dividend

# 1 - Synergy Pharmaceuticals Inc. (SGYP) — None — Sold

# 1 - Synergy Pharmaceuticals Inc. (SGYP) — None — Sold

# 1 - Verizon Communications Com — Dividend

# 1 - SC Jobs Econ DV Ath Stdnt 4.25% 8/1/24 "Y" — Interest

Brokerage account # 2 (Marked as # 2)

# 2 - Cash balance - First Clearing, LLC — Int./Div.

# 2 - Exxon Mobil Corp — Dividend

Brokerage account # 3 (Marked as # 3)

# 3 - Ameritrade MMDA Account - Cash balance — Int./Div.

# 3 - AT&T Inc. Com — Dividend — Buy

# 3 - AT&T Inc. Com — Sold

# 3 - Acasti Pharma Inc Com Cl A — Dividend — Buy

# 3 - Acasti Pharma Inc Com Cl A — Sold

# 3 - Acasti Pharma Inc Com Cl A — Buy

# 3 - Acasti Pharma Inc Com Cl A — Sold

# 3 - Acasti Pharma Inc Com Cl A — Buy

# 3 - Acasti Pharma Inc Com Cl A — Sold

# 3 - Acasti Pharma Inc Com Cl A — Buy

# 3 - Acasti Pharma Inc Com Cl A — Sold

# 3 - Acasti Pharma Inc Com Cl A — Buy

# 3 - Acasti Pharma Inc Com Cl A — Sold

# 3 - Beyond Meat Inc Com — Int./Div. — Buy

# 3 - Beyond Meat Inc Com — Sold

# 3 - Beyond Meat Inc Com — Buy

# 3 - Beyond Meat Inc Com — Sold

# 3 - Beyond Meat Inc Com — Buy

# 3 - Beyond Meat Inc Com — Sold

# 3 - Global Blood Therapeutics Inc. Com — Int./Div. — Buy

# 3 - Global Blood Therapeutics Inc. Com — Sold

# 3 - PG&E Corp Com — Int./Div. — Buy

# 3 - PG&E Corp Com — Sold

# 3 Pharmacyte Biotech Inc Com — Int./Div. — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

# 3 Pharmacyte Biotech Inc Com — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

# 3 Pharmacyte Biotech Inc Com — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

# 3 Pharmacyte Biotech Inc Com — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

# 3 Pharmacyte Biotech Inc Com — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

# 3 Pharmacyte Biotech Inc Com — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

# 3 Pharmacyte Biotech Inc Com — Buy

# 3 Pharmacyte Biotech Inc Com — Sold

#3 - Quicklogic Corp — Int./Div. — Buy

#3 - Quicklogic Corp — Sold

#3 - Roku Inc com Cl A — Int./Div. — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

#3 - Roku Inc com Cl A — Buy

#3 - Roku Inc com Cl A — Sold

# 3 - Sarepta Therapeutics Inc Com — Int./Div. — Buy

# 3 - Sarepta Therapeutics Inc Com — Sold

# 3 - Starbucks Corp Com — Int./Div. — Buy

# 3 - Starbucks Corp Com — Sold

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Dividend — Sold (part)

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Sold

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Buy

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Sold

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Buy

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Sold

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Buy

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Sold

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Buy

# 3 - Synergy Pharmaceuticals Inc Com (SGYP) — Sold

# 3 - Acasti Pharma Inc. Com Cl A — Dividend — Buy

# 3 - Roku Inc. — Dividend — Buy

South State Bank checking — None

Synovus (Formerly NBSC) — Interest

Wells Fargo, NA — Interest

Equitable Variable: EQ Aggressive (whole life policy) — None

Jefferson-Pilot Adjustable Life policy — None

UGMA # A (Marked as # A)

# A - Capital World Growth & Income Fund - Class F-1 (CWGFX) — Dividend

# A - First Clearing , LLC - Cash balance — Interest

# A American Fds Washington Mut (Edu Svgs Acct)(no control) — Int./Div.

UGMA # A, Trust 1 (Marked as # AT1)

# AT1 - First Clearing, LLC - Cash balance — Int./Div.

# AT1 - AT&T Inc. (T) — Int./Div. — Sold

# AT1 - Hartford Fortis Funds (HGOCX) — Int./Div. — Sold

# ATI - Hartford Mut Fds (HDGCX) — Int./Div. — Sold

# ATI - MFS Ser Tr XIII (DIFCX) — Int./Div. — Sold

# AT1 - Fidelity Funds Fidelity Treasury Only — Int./Div. — Buy

# AT1 - Fidelity Funds Fidelity Treasury Only — Sold (part)

UGMA # B (Marked as # B)

# B - Capital World Growth & Income Fund - F-1 (CWGFX) — Dividend

# B First Clearing , LLC - Cash balance — Interest

# B Columbia Mgmt Futre Schol 529 Collge Svng Pl (no control) — Int./Div.

In Part VII, page 4, line 1, Column B(1) for 1.25 acres Florence County received no rental income for the year therefore, column B(2) is "None".

Part VII Investments and Trust, line 96 and 108 Capital World Growth & Income Fd Inc Cl C (CWGCX) converts to Class F-1 shares after 10 years. The

exchange took place on 12/13/2016. The converted shares are called Capital World Growth & Income Fund-Class F-1 (CWCFX).

Part VII, lines 3, 10, 13, 97,100, and 109 are the money market account portions of the brokerage accounts which act as sweep accounts for uninvested cash in that

specific brokerage account. We believe these to be a widely held accounts because they are a part of the brokerage accounts.

Part VII, lines 2, 9, 12, 95, 99, and 107 are header lines for the investments listed below the specific line.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.